Literature DB >> 25876770

T Cells: Soldiers and Spies--The Surveillance and Control of Effector T Cells by Regulatory T Cells.

Bruce M Hall1.   

Abstract

Traditionally, T cells were CD4+ helper or CD8+ cytotoxic T cells, and with antibodies, they were the soldiers of immunity. Now, many functionally distinct subsets of activated CD4+ and CD8+ T cells have been described, each with distinct cytokine and transcription factor expression. For CD4+ T cells, these include Th1 cells expressing the transcription factor T-bet and cytokines IL-2, IFN-γ, and TNF-β; Th2 cells expressing GATA-3 and the cytokines IL-4, IL-5, and IL-13; and Th17 cells expressing RORγt and cytokines IL-17A, IL-17F, IL-21, and IL-22. The cytokines produced determine the immune inflammation that they mediate. T cells of the effector lineage can be naïve T cells, recently activated T cells, or memory T cells that can be distinguished by cell surface markers. T regulatory cells or spies were characterized as CD8+ T cells expressing I-J in the 1970s. In the 1980s, suppressor cells fell into disrepute when the gene for I-J was not present in the mouse MHC I region. At that time, a CD4+ T cell expressing CD25, the IL-2 receptor-α, was identified to transfer transplant tolerance. This was the same phenotype of activated CD4+ CD25+ T cells that mediated rejection. Thus, the cells that could induce tolerance and undermine rejection had similar badges and uniforms as the cells effecting rejection. Later, FOXP3, a transcription factor that confers suppressor function, was described and distinguishes T regulatory cells from effector T cells. Many subtypes of T regulatory cells can be characterized by different expressions of cytokines and receptors for cytokines or chemokines. In intense immune inflammation, T regulatory cells express cytokines characteristic of effector cells; for example, Th1-like T regulatory cells express T-bet, and IFN-γ-like Th1 cells and effector T cells can change sides by converting to T regulatory cells. Effector T cells and T regulatory cells use similar molecules to be activated and mediate their function, and thus, it can be very difficult to distinguish soldiers from spies.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  GN; T cell; Treg; cytokine; transplantation

Mesh:

Substances:

Year:  2015        PMID: 25876770      PMCID: PMC4633791          DOI: 10.2215/CJN.06620714

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  163 in total

1.  Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific.

Authors:  A M Thornton; E M Shevach
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

Review 2.  Thymic selection revisited: how essential is it?

Authors:  Harald von Boehmer; Iannis Aifantis; Fotini Gounari; Orly Azogui; Loralee Haughn; Irina Apostolou; Elmar Jaeckel; Fabio Grassi; Ludger Klein
Journal:  Immunol Rev       Date:  2003-02       Impact factor: 12.988

3.  Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules.

Authors:  G Cammarota; A Scheirle; B Takacs; D M Doran; R Knorr; W Bannwarth; J Guardiola; F Sinigaglia
Journal:  Nature       Date:  1992-04-30       Impact factor: 49.962

Review 4.  Cell therapy as a strategy to minimize maintenance immunosuppression in solid organ transplant recipients.

Authors:  Edward K Geissler; James A Hutchinson
Journal:  Curr Opin Organ Transplant       Date:  2013-08       Impact factor: 2.640

5.  T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development.

Authors:  Naganari Ohkura; Masahide Hamaguchi; Hiromasa Morikawa; Kyoko Sugimura; Atsushi Tanaka; Yoshinaga Ito; Motonao Osaki; Yoshiaki Tanaka; Riu Yamashita; Naoko Nakano; Jochen Huehn; Hans Joerg Fehling; Tim Sparwasser; Kenta Nakai; Shimon Sakaguchi
Journal:  Immunity       Date:  2012-11-01       Impact factor: 31.745

Review 6.  Do suppressor T cells exist?

Authors:  G Möller
Journal:  Scand J Immunol       Date:  1988-03       Impact factor: 3.487

Review 7.  The biology of CD2: adhesion, transmembrane signal, and regulatory receptor of immunity.

Authors:  J S Bromberg
Journal:  J Surg Res       Date:  1993-03       Impact factor: 2.192

Review 8.  Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?

Authors:  Jochen Huehn; Julia K Polansky; Alf Hamann
Journal:  Nat Rev Immunol       Date:  2009-02       Impact factor: 53.106

9.  TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.

Authors:  Liang Zhou; Jared E Lopes; Mark M W Chong; Ivaylo I Ivanov; Roy Min; Gabriel D Victora; Yuelei Shen; Jianguang Du; Yuri P Rubtsov; Alexander Y Rudensky; Steven F Ziegler; Dan R Littman
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

10.  Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells.

Authors:  B M Hall; M E Jelbart; K E Gurley; S E Dorsch
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

View more
  28 in total

Review 1.  Role of chemokines, innate and adaptive immunity.

Authors:  Kurt A Zimmerman; Katharina Hopp; Michal Mrug
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

2.  The Complex Role of Interleukin 6 in Regulating T-cell Responses during Acute Glomerulonephritis.

Authors:  Sarah Cormican; Matthew D Griffin
Journal:  J Am Soc Nephrol       Date:  2019-07-16       Impact factor: 10.121

Review 3.  Mast cells participate in allograft rejection: can IL-37 play an inhibitory role?

Authors:  Pio Conti; Alessandro Caraffa; Gianpaolo Ronconi; Spiros K Kritas; Filiberto Mastrangelo; Lucia Tettamanti; Ilias Frydas; Theoharis C Theoharides
Journal:  Inflamm Res       Date:  2018-06-30       Impact factor: 4.575

Review 4.  Regulatory T cells and minimal change nephropathy: in the midst of a complex network.

Authors:  R Bertelli; A Bonanni; A Di Donato; M Cioni; P Ravani; G M Ghiggeri
Journal:  Clin Exp Immunol       Date:  2015-10-12       Impact factor: 4.330

5.  Immature Exosomes Derived from MicroRNA-146a Overexpressing Dendritic Cells Act as Antigen-Specific Therapy for Myasthenia Gravis.

Authors:  Weifan Yin; Song Ouyang; Zhaohui Luo; Qiuming Zeng; Bo Hu; Liqun Xu; Yuan Li; Bo Xiao; Huan Yang
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

Review 6.  Regenerative immunology: the immunological reaction to biomaterials.

Authors:  Paolo Cravedi; Samira Farouk; Andrea Angeletti; Lauren Edgar; Riccardo Tamburrini; Jerome Duisit; Laura Perin; Giuseppe Orlando
Journal:  Transpl Int       Date:  2017-10-05       Impact factor: 3.782

7.  Evolution of pathologic T-cell subsets in patients with atopic dermatitis from infancy to adulthood.

Authors:  Tali Czarnowicki; Helen He; Talia Canter; Joseph Han; Rachel Lefferdink; Taylor Erickson; Stephanie Rangel; Naoya Kameyama; Hyun Je Kim; Ana B Pavel; Yeriel Estrada; James G Krueger; Amy S Paller; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2019-10-15       Impact factor: 10.793

8.  Multiple sclerosis patients have reduced resting and increased activated CD4+CD25+FOXP3+T regulatory cells.

Authors:  Nirupama D Verma; Andrew D Lam; Christopher Chiu; Giang T Tran; Bruce M Hall; Suzanne J Hodgkinson
Journal:  Sci Rep       Date:  2021-05-18       Impact factor: 4.379

9.  The effects of TNF-α/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer.

Authors:  Yang Qu; Xianhao Wang; Shuai Bai; Liling Niu; Gang Zhao; Yuan Yao; Bin Li; Hui Li
Journal:  Int J Cancer       Date:  2021-11-16       Impact factor: 7.316

Review 10.  Role of Porphyromonas gingivalis HmuY in Immunopathogenesis of Chronic Periodontitis.

Authors:  P C Carvalho-Filho; I S Gomes-Filho; R Meyer; T Olczak; M T Xavier; S C Trindade
Journal:  Mediators Inflamm       Date:  2016-06-15       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.